Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Published by: GlobalData

Published: Apr. 25, 2012 - 78 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 GlobalData Report Guidance

3 Facial Aesthetics - Device Overview

3.1 Botulinum Toxin

3.2 Dermal Fillers

3.2.1 Hyaluronic Acid Based Dermal Fillers

3.2.2 Other Dermal Fillers

4 Facial Aesthetics - Global Market Characterization

4.1 Facial Aesthetics Market, Global, Revenue ($bn), Forecast, 2011-2018

4.2 Facial Aesthetics Market, Key Trends

4.2.1 Hyaluronic Acid Based Dermal Fillers to Drive the Market for Facial Aesthetics in the Future

4.2.2 Inception of Hyaluronic Acid Based Dermal Fillers has led to the Decline of Collagen Products

4.3 Facial Aesthetics, Market Dynamics

4.3.1 Market Drivers

4.3.2 Market Restraints

5 Facial Aesthetics Market - Segment Analysis

5.1 Botulinum Toxin, Global, Revenue ($bn), Forecast, 2011–2018

5.2 Botulinum Toxin, Market Dynamics

5.2.1 Key Market Drivers: Increasing Number of Procedures and Reducing Price Trend

5.2.2 Market Growth Restraints: High Side Effects Profile and Temporary Results of Botulinum Toxin

5.3 Dermal Fillers, Global, Revenue ($m), Forecast, 2011–2018

5.4 Dermal Fillers, Market Dynamics

5.4.1 Market Drivers

5.4.2 Market Restraint

6 Facial Aesthetics Market, by Country, 2011–2018

6.1 Facial Aesthetics Market, the US, Revenue ($m), Forecast, 2011–2018

6.2 Facial Aesthetics Market, Canada, Revenue ($m), Forecast, 2011–2018

6.3 Facial Aesthetics Market, the UK, Revenue ($m), Forecast, 2011–2018

6.4 Facial Aesthetics Market, Germany, Revenue ($m), Forecast, 2011–2018

6.5 Facial Aesthetics Market, France, Revenue ($m), Forecast, 2011–2018

6.6 Facial Aesthetics Market, Italy, Revenue ($m), Forecast, 2011–2018

6.7 Facial Aesthetics Market, Spain, Revenue ($m), Forecast, 2011–2018

6.8 Facial Aesthetics Market, Japan, Revenue ($m), Forecast, 2011–2018

6.9 Facial Aesthetics Market, China, Revenue ($m), Forecast, 2011–2018

6.10 Facial Aesthetics Market, India, Revenue ($m), Forecast, 2011–2018

6.11 Facial Aesthetics Market, Australia, Revenue ($m), Forecast, 2011–2018

6.12 Facial Aesthetics Market, Brazil, Revenue ($m), Forecast, 2011–2018

7 Global Facial Aesthetics Market - Strategic Competitive Assessment

7.1 Facial Aesthetics Market, Global, Company Share (%), 2011

7.2 Botulinum Toxin Market, Global, Company Share (%), 2011

7.3 Dermal Fillers Market, Global, Company Share (%), 2011

7.4 Facial Aesthetics, Market Opportunities and Risk Evaluation

7.4.1 Opportunities

7.4.2 Risks

7.5 Facial Aesthetics Market, Key Market Participants

7.5.1 Allergan, Inc

7.5.2 Q-Med AB (Subsidiary of Galderma S.A.)

7.5.3 Mentor Worldwide LLC (Subsidiary of Ethicon, Inc.)

7.5.4 Medicis Pharmaceuticals Corporation

7.5.5 Merz GmbH & Co. KGaA

8 Facial Aesthetics Market – Strategic Pipeline Assessment

8.1 Dermal Fillers Market, List of Pipeline Products, Global, 2011

8.2 Profiles of Pipeline Products in Facial Aesthetics Market

8.2.1 Aeon Astron Corporation: Aeon Dermal Filler

8.2.2 Contura International A/S: Aquamid

8.2.3 Merz Pharma GmbH & Co. KgaA: Belotero Soft

8.2.4 Mosaic Medical Technologies, Inc: Dermal Filler

8.2.5 Allergan, Inc.: Juvederm Voluma

8.2.6 Q-Med AB: Macrolane

8.2.7 Q-Med AB: Restylane Touch

8.2.8 EternoGen, LLC: Aesthetic Procedures

8.2.9 Anika Therapeutics, Inc.: Next Generation Elevess Dermal Filler

8.2.10 FibroGen, Inc. FG-5030

8.2.11 Prollenium Medical Technologies, Inc: Revanesse Ultra

8.2.12 TEI Biosciences Inc.: Injectable Dermal Fille

8.2.13 Mentor Worldwide LLC: Puragen

8.2.14 Mentor Worldwide LLC: Puragen Plus

8.2.15 Teoxane laboratories: Teosyal Deep Lines

8.2.16 Teoxane laboratories: Teosyal First Lines

8.2.17 Teoxane laboratories: Teosyal Global Action

8.2.18 Teoxane laboratories: Teosyal Kiss

8.2.19 Teoxane laboratories: Teosyal Meso

8.2.20 Teoxane laboratories: Teosyal Touch Up

8.2.21 Teoxane laboratories: Teosyal Ultra Deep

8.3 Botulinum Toxin Market, List of Pipeline Products, Global, 2011

8.3.1 Revance Therapeutics, Inc.: RT001

8.3.2 Q-Med AB: Azzalure

8.3.3 Johnson & Johnson: PurTox

9 Appendix

9.1 Definitions

9.1.1 Facial Aesthetics

9.2 Acronyms

9.3 Sources

9.4 Research Methodology

9.5 Secondary Research

9.6 Primary Research

9.7 Models

9.8 Forecasts

9.9 Expert Panels

9.10 GlobalData Consulting

9.11 Contact Us

9.12 Disclaimer

1.1 List of Tables

Table 1: Facial Aesthetics Market, Global, Revenue ($bn), 2011–2018

Table 2: Collagen Products, The US, Number of Procedures (000’s), 2000–2011

Table 3: Botulinum Toxin, Global, Revenue ($bn), 2011–2018

Table 4: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000–2011

Table 5: Dermal Fillers, Global, Revenue ($m), 2011–2018

Table 6: Dermal Fillers Market, The US, Number of Procedures (million), 2000–2011

Table 7: Facial Aesthetics Market, the US, Revenue ($m), 2011–2018

Table 8: Facial Aesthetics Market, the US, Procedures (million), 2011

Table 9: Facial Aesthetics Market, Canada, Revenue ($m), 2011–2018

Table 10: Facial Aesthetics Market, Canada, Procedures (000’s), 2011

Table 11: Facial Aesthetics Market, the UK, Revenue ($m), 2011–2018

Table 12: Facial Aesthetics Market, the UK, Procedures (000’s), 2011

Table 13: Facial Aesthetics Market, Germany, Revenue ($m), 2011–2018

Table 14: Facial Aesthetics Market, Germany, Procedures (000’s), 2011

Table 15: Facial Aesthetics Market, France, Revenue ($m), 2011–2018

Table 16: Facial Aesthetics Market, France, Procedures (000’s), 2011

Table 17: Facial Aesthetics Market, Italy, Revenue ($m), 2011–2018

Table 18: Facial Aesthetics Market, Italy, Procedures (000’s), 2011

Table 19: Facial Aesthetics Market, Spain, Revenue ($m), 2011–2018

Table 20: Facial Aesthetics Market, Spain, Procedures (000’s), 2011

Table 21: Facial Aesthetics Market, Japan, Revenue ($m), 2011–2018

Table 22: Facial Aesthetics Market, Japan, Procedures (000’s), 2011

Table 23: Facial Aesthetics Market, China, Revenue ($m), 2011–2018

Table 24: Facial Aesthetics Market, China, Procedures (000’s), 2011

Table 25: Facial Aesthetics Market, India, Revenue ($m), 2011–2018

Table 26: Facial Aesthetics Market, India, Procedures (000’s), 2011

Table 27: Facial Aesthetics Market, Australia, Revenue ($m), 2011–2018

Table 28: Facial Aesthetics Market, Australia, Procedures (000’s), 2011

Table 29: Facial Aesthetics Market, Brazil, Revenue ($m), 2011–2018

Table 30: Facial Aesthetics Market, Brazil, Procedures (000’s), 2011

Table 31: Facial Aesthetics Market, Global, Revenue by Company ($m), 2011

Table 32: Botulinum Toxin Market, Global, Revenue by Company ($m), 2011

Table 33: Dermal Fillers Market, Global, Revenue by Company ($m), 2011

Table 34: Allergan, Key Marketed Products, Applications, Features and Benefits, 2012

Table 35: Allergan Inc., Acquires Groupe Corneal Laboratories SA, 2007

Table 36: Q-Med AB, Key Marketed Products, Applications, Features and Benefits, 2012

Table 37: Galderma Acquires Q–Med AB, 2011

Table 38: Mentor Worldwide, Key Marketed Products, Applications, Features and Benefits, 2012

Table 39: Johnson & Johnson Acquires Mentor Corporation, 2009

Table 40: Medicis, Key Marketed Products, Applications, Features and Benefits, 2011

Table 41: Merz GmbH & Co. KGaA, Key Marketed Products, Applications, Features and Benefits, 2012

Table 42: Merz Pharma Completes The Acquisition of BioForm Medical, 2010

Table 43: Dermal Fillers Market, List of Pipeline Products, Global, 2011

Table 44: Aeon Dermal Filler, Product Status

Table 45: Aquamid, Product Status

Table 46: Belotero Soft, Product Status

Table 47: Dermal Filler, Product Status

Table 48: Juvederm Voluma, Product Status

Table 49: Macrolane, Product Status

Table 50: Restylane Touch, Product Status

Table 51: Dermal Filler - Aesthetic Procedures, Product Status

Table 52: Next Generation Elevess Dermal Filler, Product Status

Table 53: FG-5030, Product Status

Table 54: Revanesse Ultra, Product Status

Table 55: Injectable Dermal Filler, Product Status

Table 56: Puragen, Product Status

Table 57: Puragen Plus, Product Status

Table 58: Teosyal Deep Lines, Product Status

Table 59: Teosyal First Lines, Product Status

Table 60: Teosyal Global Action, Product Status

Table 61: Teosyal Kiss, Product Status

Table 62: Teosyal Meso, Product Status

Table 63: Teosyal Touch Up, Product Status

Table 64: Teosyal Ultra Deep, Product Status

Table 65: Botulinum Toxin Market, List of Pipeline Products, Global, 2011

Table 66: RT001, Product Status

Table 67: Azzalure, Product Status

Table 68: PurTox, Product Status

1.2 List of Figures

Figure 1: Facial Aesthetics Market, Market Segmentation, 2012

Figure 2: Facial Aesthetics Market, Global, Revenue ($bn), 2011–2018

Figure 3: Collagen Products, The US, Number of Procedures (000’s), 2000–2011

Figure 4: Facial Aesthetics, Market Dynamics

Figure 5: Botulinum Toxin, Global, Revenue ($bn), 2011–2018

Figure 6: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000–2011

Figure 7: Dermal Fillers, Global, Revenue ($m), 2011–2018

Figure 8: Dermal Fillers Market, The US, Number of Procedures (million), 2000–2011

Figure 9: Facial Aesthetics Market, the US, Revenue ($m), 2011–2018

Figure 10: Facial Aesthetics Market, the US, Procedures (million), 2011

Figure 11: Facial Aesthetics Market, Canada, Revenue ($m), 2011–2018

Figure 12: Facial Aesthetics Market, Canada, Procedures (000’s), 2011

Figure 13: Facial Aesthetics Market, the UK, Revenue ($m), 2011–2018

Figure 14: Facial Aesthetics Market, the UK, Procedures (000’s), 2011

Figure 15: Facial Aesthetics Market, Germany, Revenue ($m), 2011–2018

Figure 16: Facial Aesthetics Market, Germany, Procedures (000’s), 2011

Figure 17: Facial Aesthetics Market, France, Revenue ($m), 2011–2018

Figure 18: Facial Aesthetics Market, France, Procedures (000’s), 2011

Figure 19: Facial Aesthetics Market, Italy, Revenue ($m), 2011–2018

Figure 20: Facial Aesthetics Market, Italy, Procedures (000’s), 2011

Figure 21: Facial Aesthetics Market, Spain, Revenue ($m), 2011–2018

Figure 22: Facial Aesthetics Market, Spain, Procedures (000’s), 2011

Figure 23: Facial Aesthetics Market, Japan, Revenue ($m), 2011–2018

Figure 24: Facial Aesthetics Market, Japan, Procedures (000’s), 2011

Figure 25: Facial Aesthetics Market, China, Revenue ($m), 2011–2018

Figure 26: Facial Aesthetics Market, China, Procedures (000’s), 2011

Figure 27: Facial Aesthetics Market, India, Revenue ($m), 2011–2018

Figure 28: Facial Aesthetics Market, India, Procedures (000’s), 2011

Figure 29: Facial Aesthetics Market, Australia, Revenue ($m), 2011–2018

Figure 30: Facial Aesthetics Market, Australia, Procedures (000’s), 2011

Figure 31: Facial Aesthetics Market, Brazil, Revenue ($m), 2011–2018

Figure 32: Facial Aesthetics Market, Brazil, Procedures (000’s), 2011

Figure 33: Facial Aesthetics Market, Global, Company Share (%), 2011

Figure 34: Botulinum Toxin Market, Global, Company Share (%), 2011

Figure 35: Dermal Fillers Market, Global, Company Share (%), 2011

Figure 36: Botulinum Toxin Product Benchmarking

Figure 37: Hyaluronic Acid Based Dermal Fillers Product Benchmarking

Figure 38: Facial Aesthetics, Market Opportunities and Risk Evaluation, 2011

Table 39: Safety and Effectiveness of Juvederm Injectable Gel with Lidocaine

Figure 40: Allergan Inc., Internal Factor Analysis, 2012

Figure 41: Q-Med AB, Internal Factor Analysis, 2012

Table 42: Reduced Pain With Use Of Proprietary Hyaluronic Acid With Lidocaine For Correction Of Nasolabial Folds: A Patient-Blinded, Prospective, Randomized Controlled Trial

Figure 43: Mentor Worldwide, Internal Factor Analysis, 2012

Figure 44: Medicis Pharmaceutical Corporation, Internal Factor Analysis, 2012

Table 45: Evaluation of Pain With the Use of Lidocaine-Mixed Radiesse Injectable Dermal Filler for the Treatment of Nasolabial Folds

Figure 46: Merz GmbH & Co. KGaA, Internal Factor Analysis, 2012

Abstract

• The key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Botulinum Toxin (Botox) and Dermal Fillers (HA fillers and Other Dermal Fillers).
• Annualized market revenue data for 2011 and forecast forward to 2018, as well as company shares data for 2011. Company shares data for Botox and Dermal Fillers for 2011 are also provided.
• Qualitative analysis of key market trends, market drivers, and restraints within the facial aesthetics market.
• Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• The key players covered are Allergan, Q-Med, Mentor, Medicis and Merz.

• Develop business strategies by understanding the trends and developments that are driving the facial aesthetics market globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What’s the next big thing in the facial aesthetics market landscape? Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global facial aesthetics market and the factors shaping it.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.